We are live on ! Find out more
ZYME icon

Zymeworks
ZYME

137 hedge funds and large institutions have $548M invested in Zymeworks in 2023 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 31

19% more funds holding

Funds holding: 115 → 137 (+22)

13% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 31

10.3% more ownership

Funds ownership: 88.53% → 98.83% (+10%)

7% more capital invested

Capital invested by funds: $512M → $548M (+$35.5M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

48% less call options, than puts

Call options by funds: $1.2M | Put options by funds: $2.3M

Holders
137
Holders Change
+22
Holders Change %
+19.13%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
53
Increased
35
Reduced
31
Closed
31
Calls
$1.2M
Puts
$2.3M
Net Calls
-$1.1M
Net Calls Change
-$2.13M

Top Buyers

1
EC
EcoR1 Capital
California
+$30M
2
BlackRock
BlackRock
New York
+$25M
3
State Street
State Street
Massachusetts
+$6.74M
4
BCM
Bridgeway Capital Management
Texas
+$5.06M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$4.85M

Top Sellers

1
PA
Perceptive Advisors
New York
-$8.62M
2
FLSM
Frazier Life Sciences Management
California
-$5.51M
3
Millennium Management
Millennium Management
New York
-$5.31M
4
RCMNY
Rubric Capital Management (New York)
New York
-$4.45M
5
RG
Redmile Group
California
-$3.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$116M +$30M +3,350,000 +33%
BI
2
BVF Inc
California
$50.7M – – –
RG
3
Redmile Group
California
$48.9M -$3.64M -406,688 -7%
Morgan Stanley
4
Morgan Stanley
New York
$47.4M -$694K -77,503 -1%
BlackRock
5
BlackRock
New York
$30.6M +$25M +2,791,105 +371%
CS
6
Credit Suisse
Switzerland
$21.7M +$214K +23,955 +1%
PA
7
Perceptive Advisors
New York
$20.9M -$8.62M -962,266 -28%
RCMNY
8
Rubric Capital Management (New York)
New York
$20.4M -$4.45M -497,155 -17%
Vanguard Group
9
Vanguard Group
Pennsylvania
$19.5M +$1.9M +212,233 +10%
BNP Paribas Asset Management
10
BNP Paribas Asset Management
France
$18.8M -$1.18M -131,872 -6%
FCM
11
Farallon Capital Management
California
$17.3M – – –
SB
12
Samsara BioCapital
California
$12.6M -$1.45M -161,812 -10%
TCM
13
Tang Capital Management
California
$9.5M – – –
State Street
14
State Street
Massachusetts
$7.83M +$6.74M +753,308 +492%
GIM
15
Granahan Investment Management
Massachusetts
$5.55M -$73.8K -8,247 -1%
Deutsche Bank
16
Deutsche Bank
Germany
$5.23M +$193K +21,603 +4%
BCM
17
Bridgeway Capital Management
Texas
$4.88M +$5.06M +565,273 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$4.86M +$4.75M +530,427 +1,684%
Arrowstreet Capital
19
Arrowstreet Capital
Massachusetts
$4.68M +$4.85M +542,230 New
AQR Capital Management
20
AQR Capital Management
Connecticut
$4.06M +$4.2M +469,466 New
Northern Trust
21
Northern Trust
Illinois
$3.64M +$3.5M +390,949 +1,300%
PIM
22
Platinum Investment Management
Australia
$3.54M +$31.4K +3,512 +0.9%
MAM
23
Monaco Asset Management
Monaco
$3.54M +$93.3K +10,420 +3%
SAM
24
Silvercrest Asset Management
New York
$3.26M +$3.37M +376,798 New
Point72 Asset Management
25
Point72 Asset Management
Connecticut
$3.18M +$1.52M +170,000 +86%
1
2 3 4 5

ZYME Hedge Fund Activity: Q2 2023 in Review

137 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2023, worth a combined $548M — up 6.9% from $512M a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new ZYME positions and 31 closed out — a net gain of 22 holders — while 35 added to existing stakes and 31 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $30M. The largest seller was Perceptive Advisors, cutting an estimated $8.62M.

  • 137 institutional investors held Zymeworks (ZYME) as of Q2 2023, up from 115 in Q1 2023.
  • Funds reported $548M of Zymeworks stock for Q2 2023, up 6.9% quarter-over-quarter.
  • 53 funds opened new Zymeworks positions in Q2 2023 and 31 closed out, a net change of +22 holders.
  • The largest Zymeworks buyer in Q2 2023 was EcoR1 Capital, an estimated $30M added.
  • The largest Zymeworks seller in Q2 2023 was Perceptive Advisors, an estimated $8.62M sold.

Based on aggregated 13F filings for Q2 2023.